RLFTY.US Relief Therapeutics Holding AG

Healthcare Biotechnology USA Stocks
0.1779 USD
Close of Nov 17, 2026
0.1677 4.05
Market cap
USD 30.2M
P/E
-
P/B
0.70x
ROE
-25.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is RLFTY.US undervalued?

Graham number

The Graham number of Relief Therapeutics Holding AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Relief Therapeutics Holding AG fundamental analysis

No fundamental analysis for Relief Therapeutics Holding AG yet.

Relief Therapeutics Holding AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Relief Therapeutics Holding AG

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages pres…

Full company profile